Patents Assigned to Chapter Diagnostics, Inc.
  • Patent number: 11680290
    Abstract: The present disclosure relates to methods of enzymatic treatment of double-stranded PCR amplified products for eliminating or minimizing primer-dimers in multiplex PCR reactions and for the efficient ligation of adapters. The present disclosure relates to methods and compositions that allow more efficient highly multiplex target amplification compared to conventional methods, compositions and kits by minimizing laboratory steps, eliminating primer-dimers and increasing the efficiency of adapter ligation. The disclosed methods use multiple target-specific primers for specific and selective amplification of targets in a subject's genome. The disclosed methods can be used for numerous downstream procedures and analysis, including DNA sequencing.
    Type: Grant
    Filed: December 19, 2019
    Date of Patent: June 20, 2023
    Assignee: Chapter Diagnostics, Inc.
    Inventors: Chunlin Wang, Zhihai Ma, Baback Gharizadeh
  • Patent number: 11261479
    Abstract: The present disclosure relates to a method of target enrichment and amplification of selective target regions of genomes or nucleic acid samples and further analysis by systems such as NGS. The disclosure provides methods and kits that can be used in numerous downstream procedures including DNA sequencing. The disclosed methods can be utilized to sequence the target nucleic acid sequences such as to detect the presence of genetic variations for biological assays, assessment of disease, to count copies of target regions, and to allow such target enrichment prior to sequencing.
    Type: Grant
    Filed: April 23, 2019
    Date of Patent: March 1, 2022
    Assignee: Chapter Diagnostics, Inc.
    Inventors: Chunlin Wang, Zhihai Ma, Baback Gharizadeh
  • Patent number: 11149322
    Abstract: The present disclosure relates to compositions and methods for detection, identification and quantification of human papillomaviruses (HPV) and clinically significant sexually transmitted infections (STI) in a single amplification reaction. The disclosed method utilizes next-generation sequencing (NGS) to sequence amplified products. The present disclosure is also directed to kits containing primers specific to multiple HPV and STI targets.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: October 19, 2021
    Assignee: Chapter Diagnostics, Inc.
    Inventors: Chunlin Wang, Zhihai Ma, Baback Gharizadeh